AHRA September/October 2023 Quick Credit

AHRA September/October 2023 Quick Credit

Pamela Habib, MD, Head of Commercial Development, Bayer Digital Solutions
Aaron Sullivan, Head of Business Development, Bayer Digital Solutions

Sponsored by: Bayer

Over the past few years, the field of AI in medical imaging has undergone a rapid but steady transformation. AI can now achieve things in radiology that few people thought possible a mere decade ago. The field is also gradually overcoming one of its most significant perceived hurdles - regulatory approval. In addition, while fear and skepticism dominated radiologists’ perception of the future of AI in their specialty a few years ago, this is no longer the case. AI-based solutions in medical imaging could improve and accelerate the detection of disease, generate in-depth risk assessment of disease development and progression, and may reduce subjectivity in the interpretation of medical imaging data. Learn more about AI in Medical Imaging, the what, how, and why in this session.

In this webinar, attendees will learn how to:

• Understand the current state of AI in medical imaging, before, during, and after image acquisition
• Learn about funding, adoption, and regulatory landscape
• Gain insight into the future steps & challenges of AI in medical imaging

Note: No CE credit is available for this archived webinar

Presented by Ari D. Goldberg, MD, PhD, Medical Director, Body Imaging, Medical Director, MRI, Loyola University Medical Center

MRI contrast agents continue to be developed, with a focus on continued improvements in stability and safety, as well as maximization of image clarity. These distinctions rest in the molecular structure of the particular gadolinium-based contrast agent. Understanding the relative safety and efficacy of these agents is important in the radiologic management of patients. During this webinar, we’ll look closely at novel advances related to MRI contrast safety and management; understanding the risks associated with various agents as well as their efficacy.

In this webinar, attendees will learn how to:

• Identify the different Gadolinium-based contrast agent classifications.
• Explain how Gadolinium-based contrast agent stability and safety is evaluated.
• Describe the concept of gadolinium-based contrast agent "relaxivity".

AHRA Member: free to members
Non-Member: $25.00
Click here to learn more about the benefits of AHRA Membership.

Presented by Bonnie Rush, RT(R)(M)(QM)
President, Breast Imaging strategies

In 1992 the FDA was tasked with developing the MQSA and by 1994 mammography service providers had to

meet the most stringent quality assurance/control program for any imaging modality. In 2019 the FDA began to review/update the entire MQSA with the goal of continuing to identify areas of improvement to increase the viability of our early detection services. Their review included analysis and responses to input open to all interested persons with a final document published early 2023. These changes – some more impacting than others - will be covered in this one credit presentation by the author of the Mammography Quality Standards Act Made Easy. Given these changes involve important processes in the imaging chain this program will enable our department to meet the mandates by the FDA implementation date of September 2024.

You will:
 • Acquire an understanding of the FDA updates
 • Recognize their value to the MQSA quality assurance program
 • Be able to implement the impacting density inform requirement
 • Learn to educate personnel, referring physicians and patients on the density inform mandate
 • Address assessment parameters for interpretive quality
 • Understand how to enhance your early detection service 
 • Feel capable of meeting the requirements in a timely manner

AHRA Member: free to members
Non-Member: $25.00
Click here to learn more about the benefits of AHRA Membership.

AHRA July/August 2023 Quick Credit

AHRA July/August 2023 Quick Credit

AHRA May/June 2023 Quick Credit

AHRA May/June 2023 Quick Credit

AHRA Quick Credit March/April 2023